Lv11
90 积分 2024-11-12 加入
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients with Active Ankylosing Spondylitis: Results from an Adaptive Seamless Phase II/III Trial
1个月前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients with Active Ankylosing Spondylitis: Results from an Adaptive Seamless Phase II/III Trial
2个月前
已完结
Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug
2个月前
已完结
Janus kinase inhibitors versus tumor necrosis factor inhibitors in rheumatoid arthritis: meta-analytical comparison of efficacy and safety
2个月前
已完结
The current status and challenges in the diagnosis and treatment of rheumatoid arthritis in China: An annual report of 2019
3个月前
已完结
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis
3个月前
已关闭
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
3个月前
已完结
SHR0302 Improves Treg/Th17 Imbalance in Patients with Systemic Lupus Erythematosus
3个月前
已完结
The burden of rheumatoid arthritis in China from 1990 to 2019 and projections to 2030
3个月前
已完结
皖公网安备34019202002308
